Hutch News

Hutch News

Stories tagged 'Clinical Research'

Dr. Joshua Hill receives Amy Strelzer Manasevit grant award

Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections

June 6, 2018 | By Mary Engel / Fred Hutch News Service

Dr. Joshua Hill, a physician-researcher at Fred Hutch who studies post-transplant complications, has received one of the most coveted honors in the transplantation field.

View story >


Fred Hutch at ASCO

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

June 5, 2018 | By Fred Hutch staff

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

View story >


Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma

‘Incredibly big change’ in treatment of deadly skin cancer, new data show

June 4, 2018 | by Susan Keown / Fred Hutch News Service

Immunotherapy drugs have transformed the treatment of a deadly skin cancer, Merkel cell carcinoma. New trial results show these drugs help many patients survive much longer than would otherwise be possible.

View story >


3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant

$20M renewal of 4-decade-long federal grant to Hutch scientists

May 31, 2018 | By Susan Keown / Fred Hutch News Service

The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.

View story >


Nanoparticles take immunotherapy in new direction

Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors

May 30, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Fan Zhang has received funding from the American Brain Tumor Association to develop nanoparticles that can tackle a type of brain cancer called glioblastoma.

View story >


Gene editing shows promise for sickle cell and related disorders

Preclinical results offer new hope in group of dangerous inborn diseases

May 23, 2018 | By Susan Keown / Fred Hutch News Service

New research, not yet in humans, suggests that a novel gene-editing strategy holds promise for people with sickle cell disease and other serious inborn disorders of hemoglobin.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.